Risk factors for Poor Response to Itraconazole in Onychomycosis Patients: A Prospective, Observational Study in China

Key Points

• Poor response to itraconazole treatment significantly correlates with advanced age and comorbid conditions.
• The study finds that 45% of patients showed inadequate improvement after treatment with itraconazole.
• Prospective observational study evaluated multiple risk factors across numerous patients diagnosed with onychomycosis.
• Understanding these risk factors may improve treatment protocols and patient outcomes for fungal infections.